A detailed history of Nisa Investment Advisors, LLC transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 105 shares of PMVP stock, worth $169. This represents 0.0% of its overall portfolio holdings.

Number of Shares
105
Previous 65 61.54%
Holding current value
$169
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$1.44 - $1.69 $57 - $67
40 Added 61.54%
105 $0
Q2 2024

Jul 19, 2024

BUY
$1.51 - $2.21 $98 - $143
65 New
65 $0
Q2 2023

Aug 11, 2023

BUY
$3.94 - $6.27 $13,730 - $21,850
3,485 New
3,485 $21,000
Q2 2022

Aug 03, 2022

SELL
$9.23 - $22.43 $11,076 - $26,916
-1,200 Closed
0 $0
Q1 2022

Apr 29, 2022

BUY
$14.86 - $23.55 $17,832 - $28,260
1,200 New
1,200 $25,000

Others Institutions Holding PMVP

About PMV Pharmaceuticals, Inc.


  • Ticker PMVP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,622,600
  • Market Cap $73.5M
  • Description
  • PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...
More about PMVP
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.